BIOMAT Database Logo BIOMAT Database Logo

Expression of cellular oncogenes in human prostatic carcinoma cell lines. 1985

A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman

Prostatic cancer is one of the most frequent forms of malignancy in Western countries. Initially, growth of the majority of prostate tumors can be manipulated by endocrine therapy. However, ultimately androgen independent tumors continue to grow. We studied the expression of oncogenes in four different human prostatic carcinoma cell lines: PC 3, PC 133, PC 135, which are androgen independent, and the hormone dependent PC 82 cell line. Large amounts of Ha-ras and myc mRNA were present in all cell lines. Transcripts of fes, int-1 and abl were never detected. In some of the cell lines the presence of N-ras, Ki-ras, myb, fos, fms and sis mRNA was observed. The PC 82 cell line showed, in addition to myc and Ha-ras high levels of fos expression. Inhibition of tumor cell proliferation by withdrawal of androgen was accompanied by a tenfold reduction of the fos mRNA level and a twofold reduction of Ha-ras transcripts. In contrast, the expression of myc was not changed.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Cellular oncogenes in human teratocarcinoma cell lines.
October 1990, International journal of andrology,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
[Expression of cellular oncogenes in human primary liver cell carcinoma].
June 1990, Zhonghua bing li xue za zhi = Chinese journal of pathology,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Expression of cellular oncogenes in teratoma-derived cell lines.
September 1985, Experimental cell research,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Expression of oncogenes in human hepatoma cell lines.
August 1988, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
January 1990, Journal of cancer research and clinical oncology,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
[Expression of proto-oncogenes in human teratocarcinoma cell lines].
January 1986, Doklady Akademii nauk SSSR,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Anchorage-independent growth and the expression of cellular proto-oncogenes in normal human epidermal keratinocytes and in human squamous cell carcinoma cell lines.
March 1991, Oral surgery, oral medicine, and oral pathology,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
[Expression of cellular oncogenes in human hepatocellular carcinoma cell line BEL 7402 and the effect of sodium butyrate on the expression of cellular oncogenes].
June 1990, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies.
October 1989, International journal of cancer,
A W Rijnders, and J A van der Korput, and G J van Steenbrugge, and J C Romijn, and J Trapman
Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines.
December 1992, Journal of medical virology,
Copied contents to your clipboard!